BioPharmaceutical Business Intelligence

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Queensland Health
Harvard Business School
Cantor Fitzgerald
Chubb
Argus Health
Federal Trade Commission
McKesson
Boehringer Ingelheim
UBS

Generated: January 22, 2018

DrugPatentWatch Database Preview

Desvenlafaxine - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for desvenlafaxine and what is the scope of desvenlafaxine freedom to operate?

Desvenlafaxine
is the generic ingredient in four branded drugs marketed by Alembic Pharms Ltd, Osmotica Pharm Corp, Sun Pharma Global, Teva Pharms Usa, Actavis Labs Fl, Lupin Ltd, Mylan Pharms Inc, Sandoz Inc, West-ward Pharms Int, Zydus Pharms Usa Inc, and Wyeth Pharms Inc, and is included in thirteen NDAs. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.

There are sixteen drug master file entries for desvenlafaxine. Three suppliers are listed for this compound. There is one tentative approval for this compound.
Tentative approvals for DESVENLAFAXINE
Applicant Application No. Strength Dosage Form
➤ Subscribe➤ Subscribe50MGTABLET, EXTENDED RELEASE;ORAL
➤ Subscribe➤ Subscribe100MGTABLET, EXTENDED RELEASE;ORAL

US Patents and Regulatory Information for desvenlafaxine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Wyeth Pharms Inc PRISTIQ desvenlafaxine succinate TABLET, EXTENDED RELEASE;ORAL 021992-003 Aug 20, 2014 AB RX Yes No ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Wyeth Pharms Inc PRISTIQ desvenlafaxine succinate TABLET, EXTENDED RELEASE;ORAL 021992-002 Feb 29, 2008 AB RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
West-ward Pharms Int DESVENLAFAXINE SUCCINATE desvenlafaxine succinate TABLET, EXTENDED RELEASE;ORAL 204082-002 Aug 28, 2017 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Lupin Ltd DESVENLAFAXINE SUCCINATE desvenlafaxine succinate TABLET, EXTENDED RELEASE;ORAL 204172-002 Jun 29, 2015 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sandoz Inc DESVENLAFAXINE SUCCINATE desvenlafaxine succinate TABLET, EXTENDED RELEASE;ORAL 204028-001 Jun 29, 2015 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Actavis Labs Fl DESVENLAFAXINE SUCCINATE desvenlafaxine succinate TABLET, EXTENDED RELEASE;ORAL 204065-002 Jul 29, 2016 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sun Pharma Global DESVENLAFAXINE desvenlafaxine fumarate TABLET, EXTENDED RELEASE;ORAL 205583-001 Jan 28, 2014 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Osmotica Pharm Corp KHEDEZLA desvenlafaxine TABLET, EXTENDED RELEASE;ORAL 204683-001 Jul 10, 2013 BC RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Wyeth Pharms Inc PRISTIQ desvenlafaxine succinate TABLET, EXTENDED RELEASE;ORAL 021992-003 Aug 20, 2014 AB RX Yes No ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Zydus Pharms Usa Inc DESVENLAFAXINE SUCCINATE desvenlafaxine succinate TABLET, EXTENDED RELEASE;ORAL 204020-001 Oct 11, 2017 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Merck
Queensland Health
Federal Trade Commission
Harvard Business School
Citi
McKinsey
Johnson and Johnson
Mallinckrodt
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot